United States - English - NLM (National Library of Medicine)

gm pharmaceuticals, inc - thuja plicata leaf (unii: r9i752fesh) (thuja plicata leaf - unii:r9i752fesh), baptisia tinctoria root (unii: 5ef0hwi5wu) (baptisia tinctoria root - unii:5ef0hwi5wu), baccharis halimifolia whole (unii: 2cv09xa44x) (baccharis halimifolia whole - unii:2cv09xa44x), lolium perenne pollen (unii: 4t81lb52r0) (lolium perenne pollen - unii:4t81lb52r0), betula lenta pollen (unii: jq5hi5004m) (betula lenta pollen - unii:jq5hi5004m), fraxinus americana pollen (unii: g684lx721q) (fraxinus americana pollen - unii:g - relief from sneezing, runny nose, itchy eyes and sinus congestion.* this product is a homeopathic dilution, formulated to support the body’s immunity for the temporary relief of allergies*

United States - English - NLM (National Library of Medicine)

gm pharmaceuticals, inc - echinacea, unspecified (unii: 4n9p6cc1dx) (echinacea, unspecified - unii:4n9p6cc1dx), thuja plicata leaf (unii: r9i752fesh) (thuja plicata leaf - unii:r9i752fesh), baptisia tinctoria root (unii: 5ef0hwi5wu) (baptisia tinctoria root - unii:5ef0hwi5wu), baccharis halimifolia whole (unii: 2cv09xa44x) (baccharis halimifolia whole - unii:2cv09xa44x), lolium perenne pollen (unii: 4t81lb52r0) (lolium perenne pollen - unii:4t81lb52r0), betula lenta pollen (unii: jq5hi5004m) (betula lenta pollen - unii:jq5hi50 - relief from sneezing, runny nose, itchy eyes and sinus congestion.* this product is a homeopathic dilution, formulated to support the body’s immunity for the temporary relief of allergies*

United States - English - NLM (National Library of Medicine)

gm pharmaceuticals, inc - paspalum notatum pollen (unii: v003shb7vk) (paspalum notatum pollen - unii:v003shb7vk), anthoxanthum odoratum pollen (unii: 2kik19r45y) (anthoxanthum odoratum pollen - unii:2kik19r45y), holcus lanatus pollen (unii: 70o1tp6h01) (holcus lanatus pollen - unii:70o1tp6h01), artemisia tridentata pollen (unii: yi19rb8yfd) (artemisia tridentata pollen - unii:yi19rb8yfd), bromus inermis pollen (unii: 766qt72bk6) (bromus inermis pollen - unii:766qt72bk6), acacia pollen (unii: 43ddr2ydyz) (acacia pollen - unii:4 - relief from sneezing, runny nose, itchy eyes and sinus congestion.           this product is a homeopathic dilution formulated to support the body's immunity for the temporary relief of allergies.

United States - English - NLM (National Library of Medicine)

gm pharmaceuticals, inc - thuja plicata leaf (unii: r9i752fesh) (thuja plicata leaf - unii:r9i752fesh), pinus strobus bark (unii: 8pj4761097) (pinus strobus bark - unii:8pj4761097), betula lenta pollen (unii: jq5hi5004m) (betula lenta pollen - unii:jq5hi5004m), cedrus deodara wood (unii: 1go876qoy2) (cedrus deodara wood - unii:1go876qoy2), fraxinus americana pollen (unii: g684lx721q) (fraxinus americana pollen - unii:g684lx721q), baptisia tinctoria root (unii: 5ef0hwi5wu) (baptisia tinctoria root - unii:5ef0hwi5wu), hydrastis - relief from sneezing, runny nose, itchy eyes and sinus congestion.* this product is a homeopathic dilution, formulated to support the body’s immunity for the temporary relief of allergies*

United States - English - NLM (National Library of Medicine)

gm pharmaceuticals inc - betula nigra pollen (unii: 93963rfo1p) (betula nigra pollen - unii:93963rfo1p), juniperus pinchotii pollen (unii: s8a4x05w7j) (juniperus pinchotii pollen - unii:s8a4x05w7j), populus deltoides subsp. monilifera pollen (unii: 5928lj1441) (populus deltoides subsp. monilifera pollen - unii:5928lj1441), melaleuca quinquenervia pollen (unii: nx974irt8e) (melaleuca quinquenervia pollen - unii:nx974irt8e), quercus gambelii pollen (unii: 9hc15x34lx) (quercus gambelii pollen - unii:9hc15x34lx), thuja occidentali - releif from sneezin,runny nose itchy eyes and sinus congestion* this product is a homeopathic dilution,formulated to support the body's immunity for the temporary releif of allergies*

United States - English - NLM (National Library of Medicine)

sun pharmaceutical industries, inc. - ciprofloxacin hydrochloride (unii: 4ba73m5e37) (ciprofloxacin - unii:5e8k9i0o4u), dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - ciprofloxacin and dexamethasone otic suspension usp is indicated for the treatment of infections caused by susceptible isolates of the designated microorganisms in the specific conditions listed below: - acute otitis externa (aoe) in pediatric (age 6 months and older), adult and elderly patients due to staphylococcus aureus and pseudomonas aeruginosa . - ciprofloxacin and dexamethasone otic suspension is contraindicated in patients with a history of hypersensitivity to ciprofloxacin, to other quinolones, or to any of the components in this medication. - use of this product is contraindicated in viral infections of the external canal, including herpes simplex infections and fungal otic infections. risk summary there are no available data on ciprofloxacin and dexamethasone otic suspension use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes. because of the minimal systemic absorption of ciprofloxacin and dexamethasone following t

United States - English - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - levofloxacin (unii: 6gnt3y5lmf) (levofloxacin anhydrous - unii:rix4e89y14) - levofloxacin anhydrous 500 mg - levofloxacin is indicated in adult patients for the treatment of nosocomial pneumonia due to methicillin-susceptible staphylococcus aureus, pseudomonas aeruginosa, serratia marcescens, escherichia coli, klebsiella pneumoniae, haemophilus influenzae, or streptococcus pneumoniae . adjunctive therapy should be used as clinically indicated. where pseudomonas aeruginosa is a documented or presumptive pathogen, combination therapy with an anti-pseudomonal β-lactam is recommended [see clinical studies (14.1)] . levofloxacin is indicated in adult patients for the treatment of community-acquired pneumonia due to methicillin-susceptible staphylococcus aureus, streptococcus pneumoniae (including multi-drug-resistant streptococcus pneumoniae [mdrsp]), haemophilus influenzae, haemophilus parainfluenzae, klebsiella pneumoniae, moraxella catarrhalis, chlamydophila pneumoniae, legionella pneumophila, or mycoplasma pneumoniae [see dosage and administration (2.1) and clinical studies (14.2)] . mdrsp isolates are isolates res

United States - English - NLM (National Library of Medicine)

nucare pharmaceuticals ,inc. - levofloxacin (unii: 6gnt3y5lmf) (levofloxacin anhydrous - unii:rix4e89y14) - levofloxacin anhydrous 750 mg - levofloxacin are indicated for the treatment of adults (≥18 years of age) with mild, moderate, and severe infections caused by susceptible isolates of the designated microorganisms in the conditions listed in this section. levofloxacin is indicated for the treatment of nosocomial pneumonia due to methicillin susceptible staphylococcus   aureus , pseudomonas   aeruginosa , serratia   marcescens , escherichia   coli , klebsiella   pneumoniae , haemophilus   influenzae , or streptococcus   pneumoniae . adjunctive therapy should be used as clinically indicated. where pseudomonas   aeruginosa is a documented or presumptive pathogen, combination therapy with an anti-pseudomonal β-lactam is recommended [see   clinical   studies   ( 14.1)] . levofloxacin is indicated for the treatment of community-acquired pneumonia due to methicillin-susceptible staphylococcus   aureus , streptococcus   pneumoniae (including multi-drug-resistant streptococcus   pneumoniae [mdrsp]), haemophilus   influenzae , haemophilus   parain

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - levofloxacin (unii: 6gnt3y5lmf) (levofloxacin anhydrous - unii:rix4e89y14) - levofloxacin anhydrous 750 mg - levofloxacin is indicated in adult patients for the treatment of nosocomial pneumonia due to methicillin-susceptible staphylococcus aureus, pseudomonas aeruginosa, serratia marcescens, escherichia coli, klebsiella pneumoniae, haemophilus influenzae, or streptococcus pneumoniae . adjunctive therapy should be used as clinically indicated. where pseudomonas aeruginosa is a documented or presumptive pathogen, combination therapy with an anti-pseudomonal β-lactam is recommended [see   clinical   studies   ( 14.1)] . levofloxacin is indicated in adult patients for the treatment of community-acquired pneumonia due to methicillin-susceptible staphylococcus aureus, streptococcus pneumoniae (including multi-drug-resistant streptococcus pneumoniae [mdrsp]), haemophilus influenzae, haemophilus parainfluenzae, klebsiella pneumoniae, moraxella catarrhalis, chlamydophila pneumoniae, legionella pneumophila, or mycoplasma pneumoniae [see   dosage   and   administration   ( 2.1)   and   clinical   studies   ( 14.2)] . mdr

United States - English - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - levofloxacin (unii: 6gnt3y5lmf) (levofloxacin anhydrous - unii:rix4e89y14) - levofloxacin anhydrous 500 mg - levofloxacin tablets are indicated for the treatment of adults (≥18 years of age) with mild, moderate, and severe infections caused by susceptible isolates of the designated microorganisms in the conditions listed in this section. levofloxacin tablets are indicated for the treatment of nosocomial pneumonia due to methicillin-susceptible staphylococcus aureus, pseudomonas aeruginosa, serratia marcescens, escherichia coli, klebsiella pneumoniae, haemophilus influenzae, or streptococcus pneumoniae. adjunctive therapy should be used as clinically indicated. where pseudomonas aeruginosa is a documented or presumptive pathogen, combination therapy with an anti-pseudomonal β-lactam is recommended [see clinical studies (14.1)]. levofloxacin tablets are indicated for the treatment of community-acquired pneumonia due to methicillin-susceptible staphylococcus aureus, streptococcus pneumoniae (including multi-drug-resistant streptococcus pneumoniae [mdrsp]), haemophilus influenzae, haemophilus parainfluenzae, klebsiell